Literature DB >> 6961406

Rat pancreatic kallikrein mRNA: nucleotide sequence and amino acid sequence of the encoded preproenzyme.

G H Swift, J C Dagorn, P L Ashley, S W Cummings, R J MacDonald.   

Abstract

We have cloned via recombinant DNA technology the mRNA sequence for rat pancreatic preprokallikrein. Four cloned overlapping double-stranded cDNAs gave a continuous mRNA sequence of 867 nucleotides beginning within the 5'-noncoding region and extending to the poly(A) tail. The mRNA sequence reveals that pancreatic kallikrein is synthesized as a prezymogen of 265 amino acids, including a proposed secretory prepeptide of 17 amino acids and a proposed activation peptide of 11 amino acids. The activation peptide, although similar in length, is distinct from those of the other classes of pancreatic serine proteases. The amino acid sequence of the predicted active form of the enzyme is closely related to the partial sequences obtained for other kallikrein-like serine proteases including rat submaxillary gland kallikrein, pig pancreatic and submaxillary gland kallikreins, the gamma subunit of mouse nerve growth factor, and rat tonin. Key amino acid residues thought to be involved in the substrate-cleavage specificity of kallikreins are retained. Hybridization analysis showed relatively high levels of kallikrein mRNA in the rat pancreas, submaxillary and parotid glands, spleen, and kidney, indicating the active synthesis of kallikrein in these tissues.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6961406      PMCID: PMC347319          DOI: 10.1073/pnas.79.23.7263

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Synthesis of kallikreins by rat kidney slices.

Authors:  K Nustad; K Vaaje; J V Pierce
Journal:  Br J Pharmacol       Date:  1975-02       Impact factor: 8.739

2.  Methylmercury as a reversible denaturing agent for agarose gel electrophoresis.

Authors:  J M Bailey; N Davidson
Journal:  Anal Biochem       Date:  1976-01       Impact factor: 3.365

3.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

4.  Method for detection of specific RNAs in agarose gels by transfer to diazobenzyloxymethyl-paper and hybridization with DNA probes.

Authors:  J C Alwine; D J Kemp; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

5.  Three-dimensional Fourier synthesis of tosyl-elastase at 3.5 å resolution.

Authors:  H C Watson; D M Shotton; J M Cox; H Muirhead
Journal:  Nature       Date:  1970-02-28       Impact factor: 49.962

6.  3' non-coding region sequences in eukaryotic messenger RNA.

Authors:  N J Proudfoot; G G Brownlee
Journal:  Nature       Date:  1976-09-16       Impact factor: 49.962

7.  Conservation of the primary structure at the 3' end of 18S rRNA from eucaryotic cells.

Authors:  O Hagenbüchle; M Santer; J A Steitz; R J Mans
Journal:  Cell       Date:  1978-03       Impact factor: 41.582

8.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.

Authors:  H Aviv; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

9.  Kallikreinlike activity in perfusates and urine of isolated rat kidneys.

Authors:  J Roblero; H Croxatto; R García; J Corthorn; E De Vito
Journal:  Am J Physiol       Date:  1976-11

10.  Terminal labeling and addition of homopolymer tracts to duplex DNA fragments by terminal deoxynucleotidyl transferase.

Authors:  R Roychoudhury; E Jay; R Wu
Journal:  Nucleic Acids Res       Date:  1976-01       Impact factor: 16.971

View more
  21 in total

1.  Purification and characterization of recombinant tissue kallikrein from Escherichia coli and yeast.

Authors:  J Wang; J Chao; L Chao
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

2.  Kallikrein-gene expression in the rat gastrointestinal tract.

Authors:  P J Fuller; K Verity; B A Matheson; J A Clements
Journal:  Biochem J       Date:  1989-11-15       Impact factor: 3.857

Review 3.  Molecular biology of tissue kallikrein.

Authors:  R J MacDonald; H S Margolius; E G Erdös
Journal:  Biochem J       Date:  1988-07-15       Impact factor: 3.857

4.  Specific identification of tissue kallikrein in exocrine tissues and in cell-free translation products with monoclonal antibodies.

Authors:  C M Woodley; J Chao; H S Margolius; L Chao
Journal:  Biochem J       Date:  1985-11-01       Impact factor: 3.857

5.  Identification and characterization of a tissue kallikrein in rat skeletal muscles.

Authors:  N Shimojo; J Chao; L Chao; H S Margolius; R K Mayfield
Journal:  Biochem J       Date:  1987-05-01       Impact factor: 3.857

6.  Kallikrein along the rabbit microdissected nephron: a micromethod for its measurement. Effect of adrenalectomy and DOCA treatment.

Authors:  J Marchetti; M Imbert-Teboul; F Alhenc-Gelas; J Allegrini; J Menard; F Morel
Journal:  Pflugers Arch       Date:  1984-05       Impact factor: 3.657

7.  Serine protease variants encoded by Echis ocellatus venom gland cDNA: cloning and sequencing analysis.

Authors:  S S Hasson; R A Mothana; T A Sallam; M S Al-balushi; M T Rahman; A A Al-Jabri
Journal:  J Biomed Biotechnol       Date:  2010-09-29

8.  Dopamine regulates expression of the glandular-type kallikrein gene at the transcriptional level in the pituitary.

Authors:  D B Pritchett; J L Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

9.  Evolution of the rat kallikrein gene family: gene conversion leads to functional diversity.

Authors:  D R Wines; J M Brady; E M Southard; R J MacDonald
Journal:  J Mol Evol       Date:  1991-06       Impact factor: 2.395

10.  Tissue-specific regulation of the expression of rat kallikrein gene family members by thyroid hormone.

Authors:  J A Clements; B A Matheson; J E Funder
Journal:  Biochem J       Date:  1990-05-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.